HIV-positive TB patients on ART (antiretroviral therapy) in Low income (World Bank)
Low income (World Bank): HIV-positive TB patients on ART (antiretroviral therapy) was 97.0% in 2024. ▲ Rising
Latest (2024)
97.0%
Change on year
up 1.0%
Rank
1st
of 11 groups
All-time high
97.0%
in 2024
All-time low
1.4%
in 2003
Years of data
21
2003–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Low income (World Bank), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on art (antiretroviral therapy) in Low income (World Bank) is 97.0%, measured in 2024. That is the highest value across all 21 years on record.
Compared with earlier readings it is up 1.0% on the previous year and up 22.8% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Low income (World Bank) peaked at 97.0% in 2024 and was at its lowest, 1.4%, in 2003.
The long-run direction has been consistently rising across the 21 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Low income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 1.4% | — |
| 2005 | 28.0% | +1900.0% |
| 2006 | 32.0% | +14.3% |
| 2007 | 32.0% | +0.0% |
| 2008 | 30.0% | -6.2% |
| 2009 | 29.0% | -3.3% |
| 2010 | 31.0% | +6.9% |
| 2011 | 36.0% | +16.1% |
| 2012 | 57.0% | +58.3% |
| 2013 | 68.0% | +19.3% |
| 2014 | 79.0% | +16.2% |
| 2015 | 86.0% | +8.9% |
| 2016 | 89.0% | +3.5% |
| 2017 | 91.0% | +2.2% |
| 2018 | 94.0% | +3.3% |
| 2019 | 96.0% | +2.1% |
| 2020 | 94.0% | -2.1% |
| 2021 | 95.0% | +1.1% |
| 2022 | 96.0% | +1.1% |
| 2023 | 96.0% | +0.0% |
| 2024 | 97.0% | +1.0% |
Biggest year-on-year movements
Years where HIV-positive TB patients on ART (antiretroviral therapy) in Low income (World Bank) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2005 | +1900.0% | 1.4% | 28.0% |
| 2012 | +58.3% | 36.0% | 57.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.4% | 1.4% | 32.0% | 6 |
| 2010s | 72.7% | 31.0% | 96.0% | 10 |
| 2020s | 95.6% | 94.0% | 97.0% | 5 |
Countries ranked near Low income (World Bank)
- 1 Seychelles 100.0% compare
- 1 Cape Verde 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Hong Kong 100.0% compare
- 1 Ecuador 100.0% compare
- 1 Burkina Faso 100.0% compare
- 1 Oman 100.0% compare
- 1 Togo 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Serbia 100.0% compare
- 1 Israel 100.0% compare
- 1 Sri Lanka 100.0% compare
- 1 Estonia 100.0% compare
- 1 Brunei 100.0% compare
- 1 Slovakia 100.0% compare
- 1 Bhutan 100.0% compare
- 1 Grenada 100.0% compare
- 1 Armenia 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Bulgaria 100.0% compare
- 1 Georgia 100.0% compare
- 1 Sierra Leone 100.0% compare
- 1 Bahrain 100.0% compare
- 1 Azerbaijan 100.0% compare
- 1 Egypt 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Guinea 100.0% compare
- 1 Tajikistan 100.0% compare
- 1 North Macedonia 100.0% compare
- 1 Saint Lucia 100.0% compare
- 1 Cuba 100.0% compare
- 1 Macao 100.0% compare
- 1 Albania 100.0% compare
- 1 Nicaragua 100.0% compare
- 1 Malta 100.0% compare
- 1 Jordan 100.0% compare
- 1 Mongolia 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Chad 100.0% compare
- 1 Qatar 100.0% compare
- 1 Malawi 100.0% compare
- 1 Iraq 100.0% compare
- 1 Tunisia 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Lebanon 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Saudi Arabia 100.0% compare
- 1 Panama 100.0% compare
- 1 Comoros 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Dominica 100.0% compare
- 1 Barbados 100.0% compare
- 1 United Arab Emirates 100.0% compare
- 1 Syria 100.0% compare
More health data for Low income (World Bank)
- Measles - number of reported cases, gaps filled 197,977 (2025)
- Diphtheria - number of reported cases, gaps filled 7,814 (2025)
- Total tetanus - number of reported cases, gaps filled 5,130 (2025)
- Pertussis - number of reported cases, gaps filled 16,008 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1,406 (2025)
- Number of under-five deaths, annual growth rate -0.6182 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate 0.2365 % change on previous year (2024)
- Number of infant deaths, annual growth rate -0.222 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 6.99 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 289.49 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Low income (World Bank)?
- Hiv-positive tb patients on art (antiretroviral therapy) in Low income (World Bank) was 97.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Low income (World Bank)?
- The highest recorded value was 97.0% in 2024.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Low income (World Bank)?
- The lowest recorded value was 1.4% in 2003.
- How does Low income (World Bank) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Low income (World Bank) ranks 1st out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Low income (World Bank)?
- Over the last ten years it is up 22.8%. The long-run trend across the full record is rising.
- Where does this Low income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 21 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).